J. Leung

Viral contamination in biologic manufacture and implications for emerging therapies

David W. Roush, S. Springs, A. Sinskey, 2020, Nature Biotechnology.

Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing

Robert J. Ballard, C. Dowd, S. Springs, 2018, PDA Journal of Pharmaceutical Science and Technology.

Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS).

R. Kiss, J. Goldmann, S. Springs, 2023, Biologicals : journal of the International Association of Biological Standardization.

Real time and noninvasive monitoring of dry powder blend homogeneity

G. K. Raju, D. L. Holt, Peter Hansen, 2001 .

Viral contamination in biologic manufacture and implications for emerging therapies

David W. Roush, S. Springs, A. Sinskey, 2020, Nature Biotechnology.

Rate‐limiting step analysis of the microbial desulfurization of dibenzothiophene in a model oil system

K. Prather, M. Mohamed, A. Abín-Fuentes, 2013, Biotechnology and bioengineering.